News People

As an advocate for the New Zealand Amyloidosis Patients Association since 2019, I am acutely aware that when there is no center of excellence or…

AbstractOur perspective addresses one of the most pressing and timely debates in contemporary neurology and health policy: whether the recent approval of anti-…

Minimally invasive skin biopsies may be used to diagnose transthyretin amyloidosis and guide treatment in people with the rare progressive disease, according to the…

ORLANDO, Fla. (Ivanhoe Newswire) --- Cardiac amyloidosis is a systemic disorder that affects the heart and can also affect other organs such as the kidneys and…

Cardiac amyloidosis (CA) is present in approximately 10% of patients with heart failure worldwide, with wild-type transthyretin-mediated amyloid cardiomyopathy (…

ransthyretin (TTR) amyloid cardiomyopathy (ATTR-CM) is a progressive, often fatal disease. TTR stabilizers bind directly to TTR, inhibiting tetramer dissociation…

Amyloidosis occurs when abnormal, misfolded proteins deposit in different parts of the body, including the carpal tunnel in the wrist. It often builds up in the…

The success rate of left atrial appendage closure to prevent stroke was high and the rate of complications was low in patients with cardiac amyloidosis, according…

TUESDAY, Feb. 3, 2026 -- In guidelines issued by the American Society of Hematology and published online Jan. 27 in Blood Advances, recommendations are presented…

Isabelle LousadaFounder & CEOAmyloidosis Research Consortium Transthyretin amyloid cardiomyopathy (ATTR-CM), including both wild-type (ATTRwt) and…